Comparison of chromosomal imbalances in neuroendocrine and non-small-cell lung carcinomas

被引:41
作者
Michelland, S [1 ]
Gazzeri, S
Brambilla, E
Robert-Nicoud, M
机构
[1] Inst Albert Bonniot, INSERM, U309, Equipe DyOGen, F-38706 La Tronche, France
[2] Inst Albert Bonniot, INSERM, Grp Rech Canc Pouman, F-38706 La Tronche, France
关键词
D O I
10.1016/S0165-4608(99)00035-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung carcinomas are represented by non-small-cell lung carcinomas (NSCLC) and neuroendocrine carcinomas (NE) which differ in their clinical presentation and prognosis. We used comparative genomic hybridization (CGH) to characterize and compare the chromosomal pattern of 11 NSCLC and 11 high-grade NE lung carcinomas. Overall, the total number of aberrations was higher in NSCLC than in high-grade NE lung tumors (p < 0.05) and gains predominated over losses in NSCLC (p < 0.0003). Gains common to both lung tumor phenotypes were detected in 1p, 1q, 3q, 5p, 6p, 8q, 12, 17q, 19p, 19q, 20p, 20q, and X, whereas common losses were found in 2q, 3p, 4p, 4q, 5q, 8p, 9p, 10p, 11p 11q, 13q, and 17p. Major gains on 18q and losses on 2p and 16q were exclusively detected in high-grade NE lung tumors. On the other hand, major gains on 2p and 15q and losses on 21q were found only in NSCLC. Furthermore, gains within 22q11 similar to q12 and 7p12 similar to p15 were associated with NSCLC(p < 0.05). The differences in the pattern and distribution of genetic changes observed in NSCLC as opposed to high-grade NE lung carcinomas suggest the existence of distinct tumorigenic pathways between these toro major classes of lung tumors. (C) Elsevier Science Inc., 1999. All rights reserved.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 49 条
[21]  
Minna John D., 1997, P849
[22]  
MIURA I, 1992, CANCER RES, V52, P1322
[23]   LOSS OF HETEROZYGOSITY OF CHROMOSOME 3P MARKERS IN SMALL-CELL LUNG-CANCER [J].
NAYLOR, SL ;
JOHNSON, BE ;
MINNA, JD ;
SAKAGUCHI, AY .
NATURE, 1987, 329 (6138) :451-454
[24]  
NISHIO H, 1992, CANCER-AM CANCER SOC, V69, P1130
[25]   Cancer statistics, 1996 [J].
Parker, SL ;
Tong, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1996, 46 (01) :5-27
[26]   Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p [J].
Petersen, I ;
Langreck, H ;
Wolf, G ;
Schwendel, A ;
Psille, R ;
Vogt, P ;
Reichel, MB ;
Ried, T ;
Diefel, M .
BRITISH JOURNAL OF CANCER, 1997, 75 (01) :79-86
[27]  
Petersen I, 1997, CANCER RES, V57, P2331
[28]   Allelic loss on chromosome 10q in human lung cancer:: association with tumour progression and metastatic phenotype [J].
Petersen, S ;
Wolf, G ;
Bockmühl, U ;
Gellert, K ;
Dietel, M ;
Petersen, I .
BRITISH JOURNAL OF CANCER, 1998, 77 (02) :270-276
[29]  
RIED T, 1994, CANCER RES, V54, P1801
[30]  
Sambrook J., 2002, MOL CLONING LAB MANU